Published in
Dove Press, Cancer Management and Research, (Volume 13), p. 8179-8189, 2021
DOI: 10.2147/cmar.s325043
Links
Tools
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer
Journal article published in 2021 by
Peter A. Fasching,
Thomas E. Delea,
Yen-Shen Lu 
,
Richard De Boer,
Sara A. Hurvitz,
Aaron Moynahan,
David Chandiwana,
Brad Lanoue,
Huilin Hu,
Astrid Thuerigen,
Joyce O'Shaughnessy
,
Richard De Boer,
Sara A. Hurvitz,
Aaron Moynahan,
David Chandiwana,
Brad Lanoue,
Huilin Hu,
Astrid Thuerigen,
Joyce O'Shaughnessy
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 